6,300
Participants
Start Date
June 30, 2013
Primary Completion Date
October 31, 2014
Study Completion Date
October 31, 2014
Ginkgolides Meglumine Injection
25mg, intravenous drip, once a day. Number of Cycles: 14 days.
CN001, Beijing
CN083, Beijing
CN048, Shenyang
CN008, Shenyang
CN006, Shenyang
CN017, Shenyang
CN007, Dalian
CN057, Jinzhou
CN041, Changchun
CN043, Changchun
CN062, Jilin
CN022, Jilin
CN058, Jilin
CN023, Siping
CN063, Ha’erbin
CN045, Ha’erbin
CN059, Ha’erbin
CN046, Ha’erbin
CN076, Ha’erbin
CN054, Baotou
CN016, Suihua
CN024, Hegang
CN025, Hegang
CN042, Hegang
CN056, Mudanjiang
CN060, Mudanjiang
CN061, Mudanjiang
CN044, Daqing
CN018, Daqing
CN003, Nanjing
CN039, Zhenjiang
CN055, Lianyungang
CN004, Yancheng
CN035, Hefei
CN036, Hefei
CN030, Jinan
CN053, Zibo
CN050, Binzhou
CN034, Tianjin
CN033, Tianjin
CN068, Nanchang
CN075, Jiujiang
CN088, Jiujiang
CN021, Jingdezhen
CN066, Yichun
CN067, Yichun
CN064, Xinyu
CN065, Xinyu
CN069, Ji’an
CN085, Ji’an
CN049, Sanming
CN047, Yiyang
CN070, Huaihua
CN084, Huaihua
CN002, Hengyang
CN079, Chenzhou
CN082, Wuhan
CN032, Wuhan
CN031, Xianning
CN077, Huanggang
CN051, Anyang
CN013, Luohe
CN015, Zhumadian
CN087, Luoyang
CN074, Luoyang
CN014, Kaifeng
CN005, Shenzhen
CN012, Xi'an
CN010, Xi'an
CN011, Xianyang
CN009, Xianyang
CN071, Baoding
CN072, Baoding
CN073, Baoding
CN027, Baotou
CN080, Cangzhou
CN029, Changzhi
CN078, Handan
CN052, Hengshui
CN026, Hohhot
CN040, Jiamusi
CN028, Taiyuan
CN020, Tangshan
CN019, Tangshan
CN038, Yuncheng
CN081, Zhuozhou
Lead Sponsor
Beijing Bionovo Medicine Development Co., Ltd.
OTHER
Jiangsu Kanion Pharmaceutical Co., Ltd
INDUSTRY